2013 American Transplant Congress
Prevascularized Tissue-Engineered Construct Serves as an Alternative Site for Pancreatic Islet Transplantation, A
Although the sites for clinical or experimental islet transplantation have been well established, the pancreatic islet survival and function in homing locations still remain unsatisfied.…2013 American Transplant Congress
Intrahepatic Natural Killer Cells Highly Expressing NKp46 Inhibit Early-Phase Post-Transplant Hepatitis C Virus Replication
Department of Surgery, Hiroshima University, Hiroshima City, Kasumi 1-2-3, Minami-ku, Japan
[Aim] The role of NK cells in pathophysiology of HCV infection was not entirely clear. Understanding the function of NK cells in HCV-infected patients may…2013 American Transplant Congress
Heat Shock Protein 90 Is Involved in Antibody-Mediated Rejection and Is a Potential Target of Anti-Rejection Therapy in Kidney Transplantation
Purpose: Heat shock protein 90 (HSP90) is a ubiquitously expressed molecular chaperone that is associated with the correct activation of client proteins. Important roles of…2013 American Transplant Congress
Treatment of Cryptococcosis in Solid-OrganTransplant Recipients: Relapse Is Rare after Discontinuation of Therapy
Background: Cryptococcosis is the third most common fungal infection in solid- organ transplant (SOT) recipients. Current treatment guidelines recommend 6-12 months of antifungal therapy; however,…2013 American Transplant Congress
Complement Fixing HLA Antibodies Predict Outcome in HLA Incompatible Renal Transplantation
Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom
HLA incompatible [HLAi] transplantation is associated with a higher incidence of antibody mediated rejection [AMR] and Transplant Glomerulopathy [TG]. In this study, we show that…2013 American Transplant Congress
Probability of Deceased Donor Kidney Transplantation Based on PRA%
Sensitization to HLA antigens creates an obstacle for the accessibility and success of kidney transplantation (KT). Highly sensitized patients have longer waiting times and some…2013 American Transplant Congress
Class I HLA Mismatches Increase Risk of Acute Rejection, Graft Loss and Formation of De Novo Class II Alloantibody
Introduction. With modern immunosuppression it is believed that HLA mismatch (mm) have little impact on kidney graft survival, except for the benefits of 0 HLA…2013 American Transplant Congress
Urea-Modified Protein Antigens to Simultaneously Assess CMV-Specific CD4 and CD8 T-Cell Responses Using a New CMV-ELISPOT Assay and Flow-Cytometry
CMV-specific T-cell monitoring is currently explored as a valuable tool to identify transplant recipients at risk for viral complications. As both CMV-specific CD4 and CD8…2013 American Transplant Congress
Prospective, Randomized Pilot Study of B-Cell Targeted Induction Therapy in Sensitized Kidney Transplant Recipients: Final Report, A
U of Cincinnati, Cincinnati; The Christ Hospital, Cincinnati
Optimal induction therapy for patients at high risk for antibody and/or cell mediated rejection has not been established. This study evaluated addition of B-cell targeting…2013 American Transplant Congress
Role of Immunoglobulin (Ig)-G Subclasses and C1q in De Novo HLA DQ DSA Kidney Transplant Outcomes, The
Background. Anti-HLA DQ antibodies are the predominant HLA class II donor-specific- antibodies (DSAs) after transplantation. Recently, de novo DQ DSA has been associated with worse…
- « Previous Page
- 1
- …
- 51
- 52
- 53
- 54
- 55
- …
- 178
- Next Page »